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Abstract
Aim—Variations in the expression of cytokines during the progression of periodontitis remain ill-
defined. We evaluated the expression of 19 cytokine genes related to T cell phenotype/function
during initiation, progression, and resolution of periodontitis, and related these to the expression of
soft and bone tissue destruction genes (TDGs).
Materials and Methods—A ligature-induced periodontitis model was used in rhesus monkeys
(M. mulatta) (n=18). Gingival tissues were taken at baseline pre-ligation, 2 weeks and 1 month
(Initiation), and 3 months (Progression) post-ligation. Ligatures were removed and samples taken
2 months later (Resolution). Total RNA was isolated and the Rhesus Gene 1.0 ST (Affymetrix)
used for gene expression analysis. Significant expression changes were validated by qRT-PCR.
Results—Disease Initiation/Progression was characterized by over-expression of Th17/Treg
cytokine genes (IL-1β, IL-6, TGFβ, and IL-21) and down-regulation of Th1/Th2 cytokine genes
(IL-18, and IL-25). Increased IL-2 and decreased IL-10 levels were seen during disease resolution.
Several Th17/Treg cytokine genes positively correlated with TDGs, whereas most Th1/Th2 genes
exhibited a negative correlation.
Conclusion—Initiation, progression and resolution of periodontitis involve over- and under-
expression of cytokine genes related to various T-helper subsets. In addition, variations in
individual T-helper response subset/genes during disease progression correlated to protective/
destructive outcomes.
Keywords
Periodontitis; T helper cytokines; gingival tissue; adaptive immunity; Matrix metalloproteinase;
RANKL
*Corresponding author: Octavio A. Gonzalez, Complete Address: Center for Oral Health Research, College of Dentistry, University of
Kentucky, 1095 VA Drive. HSRB 414 Lexington, KY 40536-0305. Phone: (859)-323-0125. Fax number: (859)-257-6566.
octavio.gonzalez@uky.edu.
DISCLOSURE
The authors report no conflicts of interest related to this study.
NIH Public Access
Author Manuscript
J Clin Periodontol. Author manuscript; available in PMC 2015 September 01.
Published in final edited form as:
J Clin Periodontol. 2014 September ; 41(9): 853–861. doi:10.1111/jcpe.12286.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
INTRODUCTION
A balanced gingival immune response to bacterial biofilms is critical to maintain a healthy
periodontium without causing tissue damage. Otherwise, a persistent inflammatory response
triggered by pathogenic biofilms, leads to destruction of the soft and bone tissues of the
periodontium, with the consequent loss of teeth (Van Dyke and Serhan, 2003). Cytokines
are central regulators of the immunoinflammatory response that are produced by various cell
types including epithelial cells, fibroblasts, dendritic cells, macrophages, and T helper (Th)
cells in response to microbes. Accordingly, the net result expression of cytokines within the
tissues will generate a specific local milieu that orchestrates the cellular and humoral
immune responses necessary to manage oral commensals and pathogens.
Cytokines can be functionally grouped as Th1, Th2, Th17, and T regulatory (Treg), based on
their expression pattern and effects on target cells or tissues. IFNγ and IL-12 are Th1
cytokines important for the activation of cell-mediated immunity to control intracellular
pathogens and autoimmunity. IL-4, IL-5, IL-13 and IL-25 are Th2 cytokines which drive
humoral immunity to control extracellular parasites and also have been involved in allergic-
type responses mediated by IgE and mast cell activation. IL-1β, IL-6, IL-21, IL-22, IL-23
and IL-17A are Th17 cytokines that enhance an immune response against extracellular
bacteria and fungi. TGFβ, IL-2 and IL-10 are considered Treg cytokines that are important
to maintain a balanced immune response through negative regulation of other T-helper
responses (Mucida and Cheroutre, 2010, Agnello et al., 2003). Recent evidence indicates
that some fully committed Th cell subsets have the ability to produce cytokines that are
normally linked to a given Th cell subset under specific conditions (e.g., Th17 cells
producing IFNγ, and Tregs producing IL-17A), which suggest that Th subsets appear to
exhibit cell plasticity in terms of cytokine production (Bluestone et al., 2009, Hirahara et al.,
2011). This versatility associated with Th responses increases the challenge of associating
unique Th response subsets/cytokines to a given disease or phase of the disease. Adding
another level of complexity, the new Th9, Th22 and follicular T-helper (Tfh) cell subsets
have been described, although their potential role in health and disease remains to be
determined (Schmitt et al., 1994, Trifari et al., 2009, Crotty, 2011).
Variations in Th cytokine levels associated with periodontal disease have been extensively
studied attempting to identify a particular Th cytokine profile/response related to early/stable
or progressive periodontal lesions. Initial studies reported inconclusive results with the role
of Th1 and Th2 responses, where both Th responses were associated with either protective
or destructive periodontal lesions (Gaffen and Hajishengallis, 2008, Gemmell et al., 2007).
Emerging evidence indicates that the recently described Th17 cytokine response appears to
play a critical role in chronic periodontitis (Adibrad et al., 2012, Cardoso et al., 2009).
Consistently, Th17 cytokines have shown the ability to enhance osteoclast differentiation
and activation of metalloproteinases (MMPs), critical mediators of soft and hard tissue
destruction in periodontitis (Okamoto and Takayanagi, 2011, van Hamburg et al., 2011).
The role of Treg in periodontitis is less understood; however it has been reported that tissues
from patients with chronic periodontitis presented an increased frequency of forkhead box
protein 3 (Foxp3+) Tregs compared with healthy tissues, which suggests that this Th subset
Ebersole et al. Page 2
J Clin Periodontol. Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
could be involved in the modulation of the local immune response in chronic periodontitis
(Cardoso et al., 2008).
Although clinical and animal studies (i.e., mice) support that cytokines are involved in the
pathogenesis of periodontal disease (Gaffen and Hajishengallis, 2008, Preshaw and Taylor,
2011), it remains unclear, what type of Th response(s) are related to initiation, progression
and resolution of periodontitis.
Using the nonhuman primate model of ligature-induced periodontitis that reflects
characteristics of human periodontitis we evaluated the expression of 19 Th cytokine genes
related to Th1/Th2/Th17/Treg responses in gingival tissues during initiation, progression
and resolution of periodontitis. Also, this model could help to delineate what type(s) of T-
cell responses most closely relate to soft and bone tissue destruction and host protection.
MATERIAL AND METHODS
Animals and diet
Rhesus monkeys (Macaca mulatta) (n=18; 10 females and 8 males) housed at the Caribbean
Primate Research Center (CPRC) at Sabana Seca, Puerto Rico, were used in these studies.
The range of age was between 12 and 23 years old (Mean=16.1±3.7). The nonhuman
primates were typically fed a 20% protein, 5% fat, and 10% fiber commercial monkey diet
(diet 8773, Teklad NIB primate diet modified: Harlan Teklad). The diet was supplemented
with fruits and vegetables, and water was provided ad libitum in an enclosed corral setting.
Ligature-induced periodontal disease and gingival tissue sample collection
Following a protocol approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Puerto Rico, anesthetized animals were examined by a single
investigator using a Maryland probe on the facial aspect of the teeth, 2 proximal sites per
tooth (mesio- and disto-buccal), excluding the canines and 3rd molars. The clinical
examination included probing pocket depth (PD), and bleeding on probing (BOP; 0–5 scale)
(Ebersole et al., 2008). At the initiation of the study, all animals were evaluated clinically for
periodontal disease, and only animals with mean bleeding on probing (BOP) of ≤1 and mean
pocket depths (PD) <3 mm were entered into the study. After taking the baseline gingival
samples, ligatures were placed on the second premolar and first and second molars of both
maxillary quadrants. Further, clinical evaluation for ligated sites was obtained and a buccal
gingival papilla from each animal was taken using a standard gingivectomy technique at 2
weeks and 1 month (initiation of disease), and 3 months (progression of disease), time in
which soft and alveolar bone destruction has been shown to occur in this model (Smith et
al., 1993, Branch-Mays et al., 2008, Moritz et al., 1998). Then, ligatures were removed after
sampling at 3 months and samples taken 2 months later (resolution). Samples were
maintained frozen at −80°C in RNAlater solution until RNA preparation for microarray and
real time RT-PCR analysis.
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Microarray and qRT-PCR
Total RNA was isolated from each gingival tissue using Trizol reagent (Invitrogen, CA), and
further cleaned up with the Qiagen RNeasy mini kit (Qiagen, Valencia, CA). All microarray
RNA expression analyses were done at the University of Kentucky Microarray facility.
Tissue RNA samples were submitted to the microarray core and RNA quality was assessed
with an Agilent 2100 Bioanalyzer. Reverse transcription of equal amounts of RNA from
each sample was performed, followed by hybridization to the GeneChip® Rhesus Gene 1.0
ST Array (Affymetrix) similar to methods we have described previously (Meka et al.,
Gonzalez et al., 2011). Briefly, 250ng of total RNA was amplified and labeled using
Ambion WT Expression and Terminal labeling kits respectively (Affymetrix), from which
3.5μg of labeled cDNA was hybridized to the GeneChip Rhesus Macaque Gene 1.0 ST
Array following the Affymetrix protocol. Post-hybridization, washing and staining of arrays
were performed in an Affymetrix GeneChip Fluidics FS450 station followed by scanning
using an Affymetrix GeneChip 3000 7G Scanner and Affymetrix Command Console
Software version 4.0. Individual samples were used for gene expression analyses.
For qRT-PCR analysis, mRNA samples (n=18) for each time point were pooled and
cytokine gene expression analyzed in triplicates. The cDNA synthesis was carried out
starting with 1μg of pooled mRNA and expression of specific transcripts for cytokines/
chemokines analyzed using the LightCycler 480 (Roche, IN). Primers for each cytokine
gene were designed using the software Primer Quest from Integrated DNA Technologies
(IDT), and synthesized by the same company (www.idtdna.com, Coralville, IA) (Table 1).
Concentration ratios for the target genes were calculated by normalizing to the housekeeping
gene GADPH.
Data Analysis
The expression intensities for all genes across the samples were estimated using the Robust
Multi-array Average (RMA) algorithm with probe-level quintile normalization, as
implemented in the Partek Genomics Suite software version 6.6. The different time points
were initially compared using one way ANOVA. For genes that had significant difference in
the time point means, two sample t-tests were used to investigate differences when
comparing baseline to each time point (i.e., 2 weeks, 1 month, 3 months and 5 months). We
also determined correlations between the expression of T-helper cytokine genes and soft and
hard tissue destruction genes during the course of the disease using a Spearman Rank
correlation analysis. Statistical significance was considered by a p value ≤ 0.05.
RESULTS
Significant increases in pocket depths were observed during initiation and progression of the
disease through the third month, and these returned to basal levels at 5 months after
removing the ligatures (Figure 1). Bleeding on probing was significantly elevated during the
initiation of disease through the first month, and then decreased to bleeding scores
comparable to basal levels at the third month even in the presence of ligatures, and 5 months
(Figure 1). Expression of T helper-related cytokine genes during initiation, progression and
resolution of periodontal disease analyzed by microarray are shown in Table 2. The
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expression of cytokines IL-1β, and IL-6 was significantly increased at 2 weeks after ligature-
induced periodontitis. In contrast, IL-18 expression was reduced. The variation in the
expression of IL-1β, IL-6 and IL-18 returned to basal levels at 1 month. A significant up-
regulation of IL-21 was observed at 3 months. Finally, a significant decrease in IL-10
expression and increased levels of IL-2 were observed at 5 months. These cytokine
expression variations observed by microarray analyses were validated by qRT-PCR
demonstrating similar trends of expression during the progression of periodontitis (Figure
2), and plotted in the context of each phase of the disease using arbitrary units (Figure 3).
The expression kinetics of genes related to soft (i.e., MMP2 and MMP9) and bone (i.e.,
RANKL and CTSK) tissue destruction genes (TDGs) is shown in Table 3. All TDGs,
showed significantly elevated expression at 2 weeks and 1 month which returned to basal
levels by 3 months. However, expression of MMP9 remained elevated during the entire
disease process and did not return to basal levels by the 5th month resolution sample.
Correlation analyses of T helper-related cytokine genes with TDGs and clinical measures of
BOP and PD are shown in Table 4. The expression of the majority of Th17/Treg cytokine
genes showed a significant positive correlation with the expression of TDGs. In contrast, the
expression of most Th1/Th2 genes was significantly negatively correlated with TDGs.
Expression of cytokines associated to the Th17 response cells, such as IL-23A, IL-17F and
IL-22 were negatively correlated with TDGs. Finally, expression of IFNγ, IL-4 and IL-21
that overlap Th1, Th2 and Th17 responses showed a negative correlation with MMP2 and
MMP9, and a positive correlation with RANKL. Significant negative correlation was
observed between IL-18 and IL23A and clinical measures; however, in contrast, IL-21
showed a positive correlation.
DISCUSSION
It has been recognized for several years that variation in the expression profile of individual
or a limited number of cytokines reflecting T-helper activities occur in periodontal disease
tissues compared to healthy tissues (Preshaw and Taylor, 2011, Gaffen and Hajishengallis,
2008). However, how these changes are related to the pathogenesis of the disease remains
unknown, since results derived from human studies cannot document the stage of the disease
reflected in the tissues. Here, we described a transcriptional analysis of an array of T-helper
cytokines and their relationship with tissue destructive genes involved in soft and bone
tissue damage during ligature-induced periodontitis using a prospective nonhuman primate
model of progressing periodontitis.
IL-1β and IL-6 were significantly over-expressed during the acute phase of disease at 2
weeks post-ligation. These changes are consistent with an important body of evidence
linking increased levels of these two pro-inflammatory cytokines to periodontitis (Okada
and Murakami, 1998) and earlier studies reporting similar changes in protein levels of pro-
inflammatory mediators including IL-1β using the same model (Smith et al., 1993, Ebersole
et al., 2000). Both cytokines have been shown to be critical drivers of the Th17 type of
response, which appears to play a critical role in periodontitis-related tissue destruction
(Gaffen and Hajishengallis, 2008). Nevertheless, IL-1β has also been related to a “non-
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classic” Th1 differentiation as well as in the expansion of Th1, Th2 and Th17 cells
(Santarlasci et al., 2013). Likewise, IL-6 also appears to induce Th2 and Tfh cell
differentiation (Diehl and Rincon, 2002, Eto et al., 2011). However, our findings are
consistent with IL-1β and IL-6 mostly driving a Th17 response, which is coincident with the
significant increases of IL-21 expression that were noted with progression of the disease at 3
months.
IL-21 is an IL-2 family member that enhances the Th17 differentiation of naïve Th cells.
Importantly, the major sources of IL-21 are activated T cells and NKT cells, but not antigen
presenting cells (Parrish-Novak et al., 2000), and the largest amounts of IL-21 are produced
by Th17 cells, which appear to use IL-21 as a positive feedback loop for maintaining and
amplifying the frequency of Th17 precursors when the supply of IL-6 is limited (Korn et al.,
2007). Based on this, IL-21 has been suggested as an important player in chronic
inflammatory disorders such as inflammatory bowel disease and rheumatoid arthritis (Fina
et al., 2008, Niu et al., 2010). The role of IL-21 in periodontal disease remains unknown;
however, in agreement with our results, a recent study demonstrated that IL-21 mRNA
levels are overexpressed in untreated chronic periodontitis patients and its expression
correlated with the expression of Th17 cytokines and clinical parameters of tissue
destruction (Dutzan et al., 2012). Although TGFβ engages multiple pathways to control T
cell differentiation, increased TGFβ levels accompanied by the presence of elevated IL-6
levels early during disease initiation suggests that it could be playing a role in Th17 rather
than in Treg differentiation which would require the presence of IL-2 (Li and Flavell, 2008).
Overall these observations are consistent with a cytokine profile driving a Th17 type of
response early in the initiation process of periodontitis, followed by a persistence of the
Th17 response related with the progression of the disease, in which IL-21 may play an
important role in the chronic nature of the disease.
Interestingly, initiation and progression of the disease were also characterized by a
significant reduction of IL-18 mRNA levels. IL-18 is a pro-inflammatory cytokine that
belongs to the IL-1 cytokine family, and promotes the development of Th1 or Th2 responses
in the presence or absence of IL-12 respectively (Biet et al., 2002). The role of IL-18 in
periodontal disease remains unclear to date and inconclusive results have been reported
regarding variation in its level during disease (Orozco et al., 2007).
Emerging evidence indicates that IL-18 could favor osteoclast formation and participate in
the bone destruction observed in rheumatoid arthritis (Zhang et al., 2013, Dai et al., 2004),
thus it would be expected that IL-18 levels could be elevated during destructive phases of
periodontitis. Nevertheless, here we observed a reduction in the mRNA basal levels of IL-18
during initiation and progression phases of the disease and negative correlation with BOP
and PD. Healthy epithelial tissues appear to have higher IL-18 mRNA levels constantly
available that are reduced after a rapid translation to protein upon cellular activation
(Kampfer et al., 1999). Consistently, IL-18 exhibited a higher mRNA level at base line
among all cytokines. Thus, the reduction of mRNA IL-18 basal levels seen during
periodontitis may be indicative of an active IL-18 translation and further increase in the
IL-18 protein levels; however this will need to be documented in future studies.
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Based on the role of IL-18 in Th differentiation, and the absence of significant changes in
IL-12 expression, one could hypothesize that if indeed IL-18 mRNA levels are associated
with decreased IL-18 protein levels, there would be a reduced likelihood for Th2 responses
to occur in early stages of the disease. This hypothesis is in some way supported by the
reduced expression levels of IL-25 during the progression of periodontitis observed by
microarray and confirmed by qRT-PCR. IL-25 is an IL-17 cytokine family member
(IL-17E) that has been related to Th2 cell responses, and enhances the expression of IL-4,
IL-5 and IL13, as well as increasing the levels of IgE, IgG1, IgA, blood eosinophilia, and
eosinophilic infiltrates in various tissues (Owyang et al., 2006). IL-25 is produced by several
cell types including T lymphocytes, mast cells, eosinophils, and basophils (Ikeda et al.,
2003, Fort et al., 2001) and its main target cells are monocytes/macrophages that are
negatively regulated by IL-25 to reduce the pro-inflammatory cytokine responses induced by
Toll-like receptor activation (Caruso et al., 2009). Variations in IL-25 levels associated with
periodontal disease have not been previously reported; however the protective role and anti-
inflammatory properties of this cytokine make it an interesting target for further studies.
Of note, increased levels of mRNA for IL-2 were significantly associated with the resolution
phase of the disease. IL-2 is produced mainly by CD4+ T helper cells in secondary
lymphoid organs, and to a lesser extent, by CD8+ T cells, natural killer cells, and natural
killer T cells (Malek, 2008). Evidence indicates that IL-2 is involved in T-helper
differentiation of Th1, Th2, Th17 and Tregs. For example, the absence of IL-2 is
accompanied by a substantial decline in the number of Treg cells, whereas the numbers of
Th17 cells increase, leading to enhanced susceptibility to inflammatory disorders. Thus,
IL-2 has been suggested to play a role in maintaining the reciprocal balance between Th17
cells and Treg cells (Littman and Rudensky, 2010). In addition, IL-2 enhances Th1 and Th2
responses by increasing the T-bet expression (Th1 transcription factor) and IL4/IL13
transcriptional activation respectively (Boyman and Sprent, 2012). The multiple roles of
IL-2 in T-helper subsets differentiation makes it difficult to interpret a potential role for IL-2
during resolution of periodontal disease and further studies will need to clarify this role.
Nevertheless, based on the IL-2 effects on T-helper differentiation, resolution of
periodontitis may require a recovery of the balance between Th17 and Treg cells which
could possibly be altered during the progression of the disease (Okui et al., 2012).
Additionally, restoration and amplification of impaired or blocked Th1 and Th2 responses,
whereby IL-2 could play a central role, may be crucial ultimately allowing the control of
periodontopathogenic bacteria.
A significant reduction in the IL-10 levels was observed during the resolution of
periodontitis. IL-10 is an anti-inflammatory cytokine expressed by virtually all T-helper
subsets and antigen presenting cells with a crucial role in preventing inflammatory and auto-
immune diseases. (Maynard and Weaver, 2008) A fine-tuned balance in the IL-10 levels
seems to be critical to efficiently remove pathogens without causing immunopathology.
(Belkaid, 2007) Thus, a reduction of IL-10 levels could be important in enabling an efficient
clearance or management of pathogenic biofilms by immune cells and ultimately resolving
periodontitis.
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Growing evidence indicates that some immune cells infiltrating the gingival tissues
(especially lymphocytes), as well as some cytokines could be enhancing the production of
tissue destructive matrix metalloproteinases (MMPs) and osteoclastogenesis (Taubman et
al., 2005). It has been somewhat controversial, which type of T-helper responses are
involved in tissue destruction during periodontitis, with both Th1 and Th17 responses
suggested to play a major role. Correlation analysis of Th cytokine genes with TDGs
indicated that the expression of most Th17/Treg genes showed significant positive
correlations with TDGs. In contrast, the expression of the majority of Th1/Th2 genes
significantly negatively correlated with TDGs. This observation suggests that soft tissue and
bone tissue damage relate more to Th17/Treg cytokines, whereas the Th1/Th2 could actually
contribute to protecting from progression of disease. However, the expression of some genes
(i.e., IFNγ, IL-4, IL-21) involved in Th1, Th2 and Th17 responses showed a negative
correlation with the MMPs but a positive correlation with RANKL. These results suggested
that the net resultant expression of Th cytokine genes could be associated with different
effects on the expression of tissue protective or destructive genes. Thus, Th1/Th2 responses
could be critical for maintaining periodontal health, but once Th17/Treg-related early tissue
damage occurs, the Th1/Th2 cell activities could also be involved in bone resorption at later
stages of the disease.
Cytokines that belong to the Th17 response such as IL-23A, IL-17F and IL-22 were
negatively correlated with TDGs and pocket depth. The effect of IL-17F and IL-22 in
activation of MMPs and osteoclastogenesis has not been well described; however these
cytokines appear to play important roles in the maintenance of mucosal barrier homeostasis
and regulation of inflammation (Chang and Dong, 2007, Sonnenberg et al., 2011). As an
example, IL-23p19 inhibits osteoclastogenesis by inducing GM-CSF production by Th17
and γδ T cells (Quinn et al., 2008). This suggests that some Th17 cytokines could be playing
a dual role as protective or destructive molecules depending on the cytokine milieu of the
tissues. Further studies exploring their active role in soft and bone tissue biology during the
course of periodontal disease will be necessary.
In general, initiation, progression and resolution of periodontitis in nonhuman primates
involve either up- or down-regulation of cytokine genes transcription related to more than
one T-helper subset. Thus, it results difficult to associate an individual T-helper cell
response subset or gene to a given phase of the disease. Post-transcriptional regulatory
mechanisms are involved in cytokine translation (e.g., RNA binding proteins and miRNAs)
(Palanisamy et al., 2012). Therefore, whether or not the transcriptional variations in Th
cytokines observed in this study are equivalent to protein levels correlating with the
presence of specific T cell subsets remain to be determined. The increasing number of
cytokines and their potential interactions through cytokines networks highlight the need of
using systems biology approaches, rather than focusing on single mediators for a clearer
understanding of the balanced nature of immune responses in health, and loss of this balance
with periodontal disease.
Since it would be impossible to reproduce this type of study in humans due to ethical
reasons, we think that cytokine changes observed in the ligature-induced model in
nonhuman primates is likely reflecting what is occurring in humans, where oscillating
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periods of initial high immunoinflammatory responses (2W-1M) followed by periods of
significant but incomplete resolution (3M) of such responses are taking place. Thus, the
frequency of oscillating periods may be determining the severity and extension of the
disease. The use of the nonhuman primate translational model combined with cellular and
molecular approaches will help to document and characterize the complexity of the dynamic
variations of T-helper cell activities and oral microbiome changes related to the
pathogenesis of periodontal disease, as well as to identifying potential new molecular
biomarkers of disease activity and resolution which could not be closely recapitulated using
in vitro or murine models, which despite their helpfulness in developing functional studies,
exhibit clear clinical and microbiological differences with respect to humans. Interestingly
and similar to what is normally seen in human studies, a great variability in cytokine gene
expression was noted. Even though this animal model allows us to control for many
extrinsic variables that can modify the host response and therefore the progression of
periodontitis, this inter-individual variation could be capitalized in future studies focused
towards identifying individual molecular profiles related to resistance or susceptibility for
periodontal disease progression and severity, which would help to build evidence that
supports the rapidly growing concept of personalized medicine/dentistry.
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CLINICAL RELEVANCE
Scientific rationale for the study
Although evidence supports that cytokines are involved in periodontitis, it remains
unclear, what type of T-cell cytokine response(s) are related to initiation, progression and
resolution of the disease.
Principal findings
Initiation, progression and resolution of periodontitis involved either up- or down-
regulation of cytokine genes related to more than one T-helper subset. Thus, it is difficult
to associate an individual T-helper response subset/gene with a given phase of the
disease.
Practical implications
Identifying profiles of specific periodontitis-related variations of T-cell cytokines could
help to define groups of multiple molecular biomarkers related to disease activity and
resolution.
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Figure 1.
Periodontal clinical measures in ligature-induced periodontitis. Pocket Depth (PD) and
bleeding on Probing (BOP) from one site per animal (n=18) were taken at baseline and
different time points after inducing disease. Data are expressed as means ± standard
deviations. *p≤0.05 when baseline values where compared to the different time points, as
determined by Student’s t test.
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Figure 2.
Cytokine expression levels determined by qRT-PCR. Significant changes in cytokine
expression by microarray were validated using qRT-PCR. Total mRNA samples (n=18)
from each time point were pooled and cytokine gene expression analyzed using triplicates.
Data are expressed as means ± standard deviations. *p≤0.05 when baseline values where
compared to the different time points, as determined by Student’s t test.
Ebersole et al. Page 15
J Clin Periodontol. Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3.
Schematic of T-helper cytokines gene expression during initiation, progression and
resolution of ligature-induced periodontal disease in nonhuman primates. Cytokines whose
gene expression showed significant increase or decrease with respect to the basal levels were
plotted using arbitrary units. The type of T-helper response(s) to which each cytokine has
been previously associated are depicted by different line types and colors.
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Table 1
Sequences of the primers used for qRT-PCR analysis.
Gene Primer sequences (5′ -3′) Tm Product Size (bp)
IL1B Forward TCCTCGACACACGCAATAAC 62.2 111
Reverse CATATGGACCAGACATCACCAA 62.0
IL-2 Forward CACTGATGTGTGAATATGCTGATG 61.9 94
Reverse GTCAGTGTTGAGATGATGCTTTG 61.9
IL-6 Forward CCTGAACCAACCACAAATGC 61.9 114
Reverse GGACTGCAGGAACTCCTTAAA 61.9
IL-10 Forward GGCGCTGTCATCGATTTCTT 62.9 103
Reverse ATGGCTTTGTAGACGCCTTTC 62.9
IL-18 Forward CTCTCTCCTGTGAGAACAGAATTA 61.5 106
Reverse CCTGGGACACTTCTCTGAAA 61.2
IL-21 Forward ACTGTGAGTGGTCAGCTATTTC 62.1 116
Reverse AGGTGATTTCCTCTTCAGCTTT 62.2
TGFB Forward GGCTACCATGCCAACTTCT 61.9 100
Reverse CCGGGTTATGCTGGTTGT 61.9
IL-25 Forward ATGGCAAGAAGGGCAACC 62.7 75
Reverse CACACACACAAGCCAAGGA 62.6
GADPH Forward GGTGTGAACCATGAGAAGTATGA 62.2 123
Reverse GAGTCCTTCCACGATACCAAAG 62.2
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